DyaxCompany Details

Get alertedif Dyax gets funded!
United States
Detailed industries:biotechnology
Company description

Dyax's mission is to discover, develop, and commercialize innovative biopharmaceuticals for unmet medical needs while delivering outstanding value to patients and stockholders. At the core of our success is our powerful and proprietary drug discovery technology, phage display. This technology provides us a unique advantage of being able to identify and develop our own clinical leads to fuel our internal pipeline. We also leverage phage display into licenses and collaborations with companies and researchers interested in furthering their own pipelines.


Funding history

DateDeal sizeInvestors 
October 10th, 2013$60,000,000-View Deal
Create alert
Want to know when Dyax gets funded?
Key people
Gustav A. ChristensenPresident and CEO
Mary Ann GrayBoard of Directors, Lead Director and A Member of the Audit Committee
Steve BernitzSr. positions - Business Development, Alliance Management & Product Development
David GrayzelDirector Corporate Development and Business Operations
Thomas R. BeckCOO, President, Chief Operating Officer
Guy Van MeterDirector, Business Development
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!